MYELONEX Trademark

Trademark Overview


On Monday, April 29, 2024, a trademark application was filed for MYELONEX with the United States Patent and Trademark Office. The USPTO has given the MYELONEX trademark a serial number of 98525965. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 8, 2025. This trademark is owned by Avstera Therapeutics Corp.. The MYELONEX trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for scientific and research use; Cells for scientific, laboratory or medical research; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Stem cells for research or scientific purposes; Stem cells for research purposes; Stem cells for scientific and medical research

Research and development in the field of microorganisms and cells; Research in the field of cell engineering technology; Research of induced pluripotent stem cells; Culturing of cells for others for scientific research purposes; Stem cell research services
myelonex

General Information


Serial Number98525965
Word MarkMYELONEX
Filing DateMonday, April 29, 2024
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2024

Trademark Statements


Goods and ServicesCells for scientific and research use; Cells for scientific, laboratory or medical research; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Stem cells for research or scientific purposes; Stem cells for research purposes; Stem cells for scientific and medical research
Goods and ServicesResearch and development in the field of microorganisms and cells; Research in the field of cell engineering technology; Research of induced pluripotent stem cells; Culturing of cells for others for scientific research purposes; Stem cell research services

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, April 29, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 29, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAvstera Therapeutics Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMALVERN, PA 19355

Party NameAvstera Therapeutics Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMALVERN, PA 19355

Trademark Events


Event DateEvent Description
Tuesday, April 30, 2024NEW APPLICATION ENTERED
Wednesday, October 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 4, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 8, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, September 8, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, November 14, 2024ASSIGNED TO EXAMINER